Overexpression of miR-21 Promotes an In vitro Metastatic Phenotype by Targeting the Tumor Suppressor RHOB

被引:94
作者
Connolly, Erin C. [1 ,2 ]
Van Doorslaer, Koenraad [2 ]
Rogler, Leslie E. [1 ]
Rogler, Charles E. [1 ,2 ]
机构
[1] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Med, Div Hepatol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
关键词
HEPATOCELLULAR-CARCINOMA; MICRORNA-21; TARGETS; INTRAHEPATIC METASTASIS; EXPRESSION; CANCER; INVASION; GENE; PROGRESSION; ADHESION; GTPASE;
D O I
10.1158/1541-7786.MCR-09-0465
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis is a multistep process that involves the deregulation of oncogenes and tumor suppressors beyond changes required for primary tumor formation. RHOB is known to have tumor suppressor activity, and its knockdown is associated with more aggressive tumors as well as changes in cell shape, migration, and adhesion. This study shows that oncogenic microRNA, miR-21, represses RHOB expression by directly targeting the 3' untranslated region. Loss of miR-21 is associated with an elevation of RHOB in hepatocellular carcinoma cell lines Huh-7 and HepG2 and in the metastatic breast cancer cell line MDA-MB-231. Using in vitro models of distinct stages of metastasis, we showed that loss of miR-21 also causes a reduction in migration, invasion, and cell elongation. The reduction in migration and cell elongation can be mimicked by overexpression of RHOB. Furthermore, changes in miR-21 expression lead to alterations in matrix metalloproteinase-9 activity. Therefore, we conclude that miR-21 promotes multiple components of the metastatic phenotype in vitro by regulating several important tumor suppressors, including RHOB. Mol Cancer Res; 8(5); 691-700. (C)2010 AACR.
引用
收藏
页码:691 / 700
页数:10
相关论文
共 33 条
[1]   Clustering and conservation patterns of human microRNAs [J].
Altuvia, Y ;
Landgraf, P ;
Lithwick, G ;
Elefant, N ;
Pfeffer, S ;
Aravin, A ;
Brownstein, MJ ;
Tuschl, T ;
Margalit, H .
NUCLEIC ACIDS RESEARCH, 2005, 33 (08) :2697-2706
[2]   The regulation of genes and genomes by small RNAs [J].
Ambros, Victor ;
Chen, Xuemei .
DEVELOPMENT, 2007, 134 (09) :1635-1641
[3]   The role of microRNAs in metastasis and epithelial-mesenchymal transition [J].
Bracken, C. P. ;
Gregory, P. A. ;
Khew-Goodall, Y. ;
Goodall, G. J. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (10) :1682-1699
[4]   MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G [J].
Chen, Yang ;
Liu, Wei ;
Chao, Tengfei ;
Zhang, Yu ;
Yan, Xingqi ;
Gong, Yanhua ;
Qiang, Boqin ;
Yuan, Jiangang ;
Sun, Maosheng ;
Peng, Xiaozhong .
CANCER LETTERS, 2008, 272 (02) :197-205
[5]   Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype [J].
Connolly, Erin ;
Melegari, Margherita ;
Landgraf, Pablo ;
Tchaikovskaya, Tatyana ;
Tennant, Bud C. ;
Slagle, Betty L. ;
Rogler, Leslie E. ;
Zavolan, Mihaela ;
Tuschl, Thomas ;
Rogler, Charles E. .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (03) :856-864
[6]   RECK gene expression in hepatocellular carcinoma: Correlation with invasion-related clinicopathological factors and its clinical significance [J].
Furumoto, K ;
Arii, S ;
Mori, A ;
Furuyama, H ;
Rivas, MJG ;
Nakao, T ;
Isobe, N ;
Murata, T ;
Takahashi, C ;
Noda, M ;
Imamura, M .
HEPATOLOGY, 2001, 33 (01) :189-195
[7]   MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators [J].
Gabriely, Galina ;
Wurdinger, Thomas ;
Kesari, Santosh ;
Esau, Christine C. ;
Burchard, Julja ;
Linsley, Peter S. ;
Krichevsky, Anna M. .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (17) :5369-5380
[8]   Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis [J].
Gomaa, Asmaa Ibrahim ;
Khan, Shahid A. ;
Toledano, Mireille B. ;
Waked, Imam ;
Taylor-Robinson, Simon D. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (27) :4300-4308
[9]  
HIMELSTEIN BP, 1994, INVAS METAST, V14, P246
[10]  
Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213